During the past decade, Smolensk regional hospital on Smolensk railway station conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 2 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 2 clinical trials were completed. i.e. 50% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Smolensk regional hospital on Smolensk railway station" #1 collaborator was "Chemical Diversity Research Institute" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Smolensk regional hospital on Smolensk railway station" are "Arthritis, Psoriatic" (4 trials), "COVID-19" (1 trials) and "Pulmonary Disease, Chronic Obstructive" (1 trials). Many other conditions were trialed in "Smolensk regional hospital on Smolensk railway station" in a lesser frequency.

Most popular intervention types in "Smolensk regional hospital on Smolensk railway station" are "Drug" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Guselkumab" (3 trials), "Favipiravir" (1 trials), "Golimumab" (1 trials) and "Guselkumab 100 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Smolensk regional hospital on Smolensk railway station" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Smolensk regional hospital on Smolensk railway station". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Smolensk regional hospital on Smolensk railway station, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Smolensk regional hospital on Smolensk railway station, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".